Could It Be CSID? Podcast

Podcast von CSID (Congenital Sucrase-Isomaltase Deficiency)

Englisch

Wissenschaft & Technologie

Dann 4,99 € / Monat. Jederzeit kündbar.

20 Stunden Hörbücher / Monat
Podcasts nur bei Podimo
Alle kostenlosen Podcasts

Mehr Could It Be CSID? Podcast

Forget heart to heart, these conversations are all gut to gut. Are you or your patients suffering with gas, bloating, diarrhea? Have you ruled out celiac disease, gluten sensitivity, and other more common diseases? What’s left? Could your stomach issues be due to your body’s inability to break down sugar (sucrose)? Let us break it down for you! Our special guests are qualified medical professionals with experience in this much overlooked and often misdiagnosed disease. Tune in as we explore why this rare disease is rarely diagnosed, and when and why you should consider it in the future. This content is supported by QOL Medical, LLC.

Alle Folgen

6 Folgen

Could It Be CSID with Christopher Hayes, MD

27. Juni 2025 - 28 min

Could It Be CSID with Melissa Lukes, APRN-CNP

This content is supported by QOL Medical, LLC. Sucraid® (sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older. Sucraid® may cause a serious allergic reaction. If you notice any swelling or have difficulty breathing, get emergency help right away. Learn more about the risks here https://www.sucraid.com/risk#isi [https://urldefense.proofpoint.com/v2/url?u=https-3A__www.youtube.com_redirect-3Fevent-3Dvideo-5Fdescription-26redir-5Ftoken-3DQUFFLUhqbW9mdGpidU4xX2RCUkpxNE5CSlpLWmV6QXRPQXxBQ3Jtc0trV2p4ZkQ5bDJMODNOMnBjTUdPUUgyLVFYZUExcUZvUk5sN21iOXY2U2dCd1FRZW1od0xDeG0wZ2pOUktINEFsVUo3SGpRRms3dEQwME84TlRyNHI0TGVOV2NKYlFLT3ZZOF9DWFkyS0R1ZmplOUJONA-26q-3Dhttps-253A-252F-252Fwww.sucraid.com-252Frisk-2523isi-26v-3DwscwbbxWD6k&d=DwMGaQ&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=IzVYdDx0BgL5C7iGv3zgEc0Fa-XJnPEygoabSJvY7NI&m=K51Qwy2Fqq4yI9ZzpH8zHlgSM_qAzRF7EBFDg2Yanwruy6XPGmgNCsgwaunz0PMj&s=MiII4e_FX2tFOcL7t6jMzWZu8881U33_5re9gpV85q0&e=]. See Prescribing Information at: https://bit.ly/2EyKpG5 [https://urldefense.proofpoint.com/v2/url?u=https-3A__www.youtube.com_redirect-3Fevent-3Dvideo-5Fdescription-26redir-5Ftoken-3DQUFFLUhqa1pPQ3RYTmNTaUczRF80bkhQYzh3Z1hrNjhmQXxBQ3Jtc0tuNXdrNXhmakI2TU9URzFNSVY1emJGZ2FaOWFKblk1aXlhWTBmS0FCZHdVN3JXVGozYURmNFM3RGxSVmc1NXhzaUJ5anlVT2VWdXRKeU9DQmt0NE9leUpKWU5OcmI1cU9nMFhqT04tSGU1SEJybDNQaw-26q-3Dhttps-253A-252F-252Fbit.ly-252F2EyKpG5-26v-3DwscwbbxWD6k&d=DwMGaQ&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=IzVYdDx0BgL5C7iGv3zgEc0Fa-XJnPEygoabSJvY7NI&m=K51Qwy2Fqq4yI9ZzpH8zHlgSM_qAzRF7EBFDg2Yanwruy6XPGmgNCsgwaunz0PMj&s=NJbVbWswpgMxY47UCVAHwdh82AUhNjz-CifWwNpwnRw&e=].

11. Sept. 2024 - 21 min